iifl-logo-icon 1

Marksans Pharma Ltd Corporate Actions

272.93
(1.36%)
Feb 7, 2025|03:31:19 PM

CORPORATE ACTIONS

09/02/2024calendar-icon
08/02/2025calendar-icon

30 May 2024

12:00 AM

Dividend

Dividend Amount: 0.6

Record Date: 17 Sep, 2024

arrow

23 Oct 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

19 Aug 2024

12:00 AM

AGM

Announcement Date: 19 Aug, 2024

arrow

Marksans Pharma: Related News

Marksans Pharma gets USFDA approval for anti-allergy drug
22 Nov 2024|02:54 PM

The US Food and Drug Administration (FDA) approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.